Whatever happened to thrombopoietin?

被引：27

作者：

Kuter, DJ ^{[1
]}

机构：

[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Hematol Unit, Boston, MA 02114 USA

来源：

TRANSFUSION | 2002年 / 42卷 / 03期

关键词：

D O I：

10.1046/j.1537-2995.2002.00056.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：279 / 283

页数：5

共 48 条

[1]

Aldaabil R, 1997, BLOOD, V90, P4517

[2] Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-mpl [J].

Alexander, WS ;

Roberts, AW ;

Nicola, NA ;

Li, RL ;

Metcalf, D .

BLOOD, 1996, 87 (06) :2162-2170

[3] A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia [J].

Archimbaud, E ;

Ottmann, OG ;

Yin, JAL ;

Lechner, K ;

Dombret, H ;

Sanz, MA ;

Heil, G ;

Fenaux, P ;

Brugger, W ;

Barge, A ;

O'Brien-Ewen, C ;

Matcham, J ;

Hoelzer, D .

BLOOD, 1999, 94 (11) :3694-3701

[4]

Basser, 1997, BLOOD, V90, P2513

[5] Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer [J].

Basser, RL ;

Rasko, JEJ ;

Clarke, K ;

Cebon, J ;

Green, MD ;

Hussein, S ;

Alt, C ;

Menchaca, D ;

Tomita, D ;

Marty, J ;

Fox, RM ;

Begley, CG .

LANCET, 1996, 348 (9037) :1279-1281

[6] Enhancement of platelet recovery after myelosuppressive chemotherapy by recombinant human megakaryocyte growth and development factor in patients with advanced cancer [J].

Basser, RL ;

Underhill, C ;

Davis, I ;

Green, MD ;

Cebon, J ;

Zalcberg, J ;

MacMillan, J ;

Cohen, B ;

Marty, J ;

Fox, RM ;

Begley, CG .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (15) :2852-2861

[7] Human platelets display high-affinity receptors for thrombopoietin [J].

Broudy, VC ;

Lin, NL ;

Sabath, DF .

BLOOD, 1997, 89 (06) :1896-1904

[8]

CarverMoore K, 1996, BLOOD, V88, P803

[9]

Choi ES, 1996, BRIT J HAEMATOL, V95, P227

[10] Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine [J].

Cwirla, SE ;

Balasubramanian, P ;

Duffin, DJ ;

Wagstrom, CR ;

Gates, CM ;

Singer, SC ;

Davis, AM ;

Tansik, RL ;

Mattheakis, LC ;

Boytos, CM ;

Schatz, PJ ;

Baccanari, DP ;

Wrighton, NC ;

Barrett, RW ;

Dower, WJ .

SCIENCE, 1997, 276 (5319) :1696-1699

← 1 2 3 4 5 →